Three innovative teams were honored with this year’s Nathaniel Bowditch Prize, which recognized their significant contributions to enhance the delivery of quality patient care while also reducing the cost of that care.
Three teams honored with annual Bowditch Prize
CURRENT-DAY NAVIGATOR: Hutter, at left, is congratulated by Warshaw and Minehan.
Three innovative teams were honored with this year’s Nathaniel Bowditch Prize, which recognized their significant contributions to enhance the delivery of quality patient care while also reducing the cost of that care. The annual award is named for the self-taught 19th century celestial navigator who helped raise funds for the construction of the MGH in the early 1800s.
“We don’t often stop to recognize our colleagues who work continually – and many times, unnoticed – to make a difference in our everyday work lives,” said David F. Torchiana, MD, MGPO chairman and CEO. “The Bowditch Prize gives all of us who work at MGH the opportunity to do just that – to acknowledge our co-workers and to thank them in a tangible way for all they have done and continue to do in developing new ways of practice and creating a workplace that is rich with creativity and individuality.”
The Antimicrobial Stewardship Team, led by David Hooper, MD, chief of the Infection Control Unit, was recognized for improving the timeliness of appropriate antibiotic use in sick hospitalized patients while minimizing antibiotic overuse, resulting in a 9 percent decrease in total antimicrobial expenditures during the 2012 fiscal year.
The MGH Department of Surgery’s Quality and Safety Program, led by Matthew Hutter, MD, MPH, was
selected for its work in leading quality and safety improvements in the department and across the hospital, resulting in a 20 percent reduction in the Department of Surgery’s readmission rate over the past three years.
And, the MGH Diabetes Care Redesign Group, led by Debra Wexler, MD, and Stephanie Eisenstat, MD, was honored for significant improvements in insulin management and for generating enormous momentum for diabetes care improvement across the institution. The processes they created will be implemented in all primary care practices by the Primary Care Transformation Council in the first half of 2013.
On May 12, during the 13th annual Bowditch ceremony in the Trustees Room, Andrew Warshaw, MD, former MGH surgeon-in-chief and chairman of the Bowditch Prize Selection Committee, commended each member of the winning teams and took time to thank and congratulate the other 10 groups and individuals nominated this year. “As in past years, we had a very difficult time making a decision,” he said. “All the nominees were outstanding, and every effort important.”
Peter L. Slavin, MD, MGH president, said, “I congratulate the winners of this year’s Bowditch Prize and applaud all of you who have been nominated for this distinction. Your desire to think creatively and strengthen the already high-quality care we deliver to our patients helps make the MGH a leading health care resource for the community, the region and the world.”
MGH Board of Trustees Chair Cathy Minehan said the board established the Bowditch Prize in 2000 through the generosity of Charles and Nancy Munger and the Alfred C. Munger Foundation.